Tiziana reports data from exploratory trial of nasally administered foralumab for COVID-19 Feb. 2, 2021
Prothena plans phase III study of birtamimab for patients with Mayo stage IV AL amyloidosis Feb. 2, 2021
Ampio expands phase I trial of Ampion for COVID-19 respiratory distress based on early data Feb. 2, 2021
T-DXd shows preliminary evidence of antitumor activity in metastatic HER2-overexpressing NSCLC Feb. 2, 2021
RSS